Division of Biological Sciences and Engineering, Netaji Subhas Institute of Technology, Dwarka, New Delhi 110078, India.
Curr Top Med Chem. 2018;18(11):925-945. doi: 10.2174/1568026618666180711154110.
Despite several advancements in antifungal drug discovery, fungal diseases like Invasive Candidiasis (IC) still remain associated with high rates of morbidity and mortality worldwide. Thus there is an enormous need for anti-Candida drugs.
The main objectives of the work included: 1. To investigate therapeutically significant classes of secondary metabolites produced by S. chrestomyceticus strain ADP4. 2. To investigate and analyze inhibition of significant virulence attributes of C. albicans, such as, biofilm and secretory hydrolytic enzymes by ADP4 secondary metabolites. 3. Mechanistic analysis of probable compounds for their site of action on Secretary Aspartyl Proteinase 3 (Sap3).
Metabolite extract-SDB (MESDB) of S. chrestomyceticus strain ADP4 was fractionated on silica gel column chromatography. Fractions were analyzed for anti-Candida activity by disc diffusion assay. Active fractions were further purified by differential solvent treatment. MIC90 values were determined by broth dilution method. MFC was based on counting viable cells. Inhibition of yeast to hyphae transition and that of production of hydrolytic enzymes were estimated by plate assays. GC-MS of MESDB and Partially Purified Metabolite preparations (PPMs) was done. GRIP docking studies with Sap 3 of C. albicans was done using VLife MDS 4.6 software.
Chemical profiling showed that ADP4 secondary metabolites contained alkaloids, flavonoids, polyphenols, terpenoids and triterpenes. The MESDB and the PPMs showed low or no cytotoxicity but were able to effectively contain virulence attributes of Candida pathogen. Docking studies revealed that some of the probable compounds have affinity for aspartic acid residue in Sap3 enzyme of C. albicans.
Secondary metabolite of strain ADP4 included important classes of therapeutically important compounds. Their anti-Candida activity was mediated by inhibition of critical virulence factors of the pathogen.
尽管在抗真菌药物发现方面取得了一些进展,但真菌感染疾病(如侵袭性念珠菌病)仍然在全球范围内导致高发病率和死亡率。因此,对抗真菌药物有巨大的需求。
该工作的主要目标包括:1. 研究 S. chrestomyceticus 菌株 ADP4 产生的具有治疗意义的次级代谢产物类别。2. 研究和分析 ADP4 次级代谢产物对 C. albicans 重要毒力特性(如生物膜和分泌水解酶)的抑制作用。3. 对可能的化合物进行机制分析,以确定其在 Secretary Aspartyl Proteinase 3 (Sap3) 上的作用部位。
采用硅胶柱层析对 S. chrestomyceticus 菌株 ADP4 的代谢物提取物-SDB(MESDB)进行分离。通过圆盘扩散试验分析各馏分的抗念珠菌活性。采用差溶剂处理进一步纯化活性馏分。采用肉汤稀释法测定 MIC90 值。MFC 基于计数活菌。通过平板试验评估酵母向菌丝体的转变抑制作用和水解酶产生的抑制作用。对 MESDB 和部分纯化代谢产物(PPMs)进行 GC-MS 分析。采用 VLife MDS 4.6 软件对 C. albicans Sap3 进行 GRIP 对接研究。
化学分析表明,ADP4 次级代谢产物含有生物碱、类黄酮、多酚、萜类和三萜类化合物。MESDB 和 PPMs 表现出低或无细胞毒性,但能够有效抑制念珠菌病原体的毒力特性。对接研究表明,一些可能的化合物与 C. albicans Sap3 酶中的天冬氨酸残基具有亲和力。
菌株 ADP4 的次级代谢产物包括具有治疗意义的重要化合物类别。它们的抗念珠菌活性是通过抑制病原体关键毒力因子介导的。